Worldwide, breast cancer has become the most diagnosed cancer with ~15% of these cases being triple negative, which is defined by absent/low expression of the hormone receptors, estrogen receptor and progesterone receptor, and lack of amplification of human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.